158 related articles for article (PubMed ID: 22282960)
1. Utility of methyl 2-isothiocyanatobenzoate in the synthesis of some new quinazoline derivatives as potential anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Bayomi AA
Arzneimittelforschung; 2011; 61(12):719-26. PubMed ID: 22282960
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of gamma-irradiation.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; Galal M
Arzneimittelforschung; 2010; 60(1):48-55. PubMed ID: 20184227
[TBL] [Abstract][Full Text] [Related]
4. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety.
Ghorab MM; Shaaban MA; Refaat HM; Heiba HI; Ibrahim SS
Eur J Med Chem; 2012 Jul; 53():403-7. PubMed ID: 22583778
[TBL] [Abstract][Full Text] [Related]
5. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MG
Arzneimittelforschung; 2012 Jan; 62(1):46-52. PubMed ID: 22331763
[TBL] [Abstract][Full Text] [Related]
7. Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation.
Ghorab MM; Ragab FA; Heiba HI; Nissan YM; Ghorab WM
Arch Pharm Res; 2012 Aug; 35(8):1335-46. PubMed ID: 22941476
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives.
El-Said MS; El-Gazzar MG; Al-Dosari MS; Ghorab MM
Arzneimittelforschung; 2012 Mar; 62(3):149-56. PubMed ID: 22270843
[TBL] [Abstract][Full Text] [Related]
9. Novel pyrazole derivatives as anticancer and radiosensitizing agents.
Aly HM; El-Gazzar MG
Arzneimittelforschung; 2012 Mar; 62(3):105-12. PubMed ID: 22407898
[TBL] [Abstract][Full Text] [Related]
10. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; El-Hazek RM
Eur J Med Chem; 2011 Oct; 46(10):5120-6. PubMed ID: 21890248
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and docking studies of some novel quinoline derivatives bearing a sulfonamide moiety as possible anticancer agents.
Ghorab MM; Ragab FA; Hamed MM
Arzneimittelforschung; 2010; 60(3):141-8. PubMed ID: 20422946
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity.
Bashandy MS; Al-Said MS; Al-Qasoumi SI; Ghorab MM
Arzneimittelforschung; 2011; 61(9):521-6. PubMed ID: 22029229
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
Rhee HK; Yoo JH; Lee E; Kwon YJ; Seo HR; Lee YS; Choo HY
Eur J Med Chem; 2011 Sep; 46(9):3900-8. PubMed ID: 21704436
[TBL] [Abstract][Full Text] [Related]
15. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs.
Khalil AA; Abdel-Hamide SG; Al-Obaid AM; El-Subbagh HI
Arch Pharm (Weinheim); 2003 Apr; 336(2):95-103. PubMed ID: 12761762
[TBL] [Abstract][Full Text] [Related]
16. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Soliman AM
Eur J Med Chem; 2016 Jul; 117():8-18. PubMed ID: 27085944
[TBL] [Abstract][Full Text] [Related]
18. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
Papadopoulou MV; Bloomer WD
Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
Alafeefy AM; Ashour AE
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
